ergotamine and Fibrosis

ergotamine has been researched along with Fibrosis in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (55.56)	18.2507
2000's	3 (33.33)	29.6817
2010's	1 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhattacharyya, S; Davar, J; Mikhailidis, DP; Schapira, AH	1
Glockner, J; Miller, FA; Murad, MH	1
Bagheri, H; Montastruc, JL; Pathak, A	1
Seaton, A	1
Allen, MB; Muers, MF; Tosh, G; Walters, G	1
Faber, L	1
Creutzig, A	1
Bates, HR	1

Reviews

1 review(s) available for ergotamine and Fibrosis

Article	Year
Drug-induced fibrotic valvular heart disease. Lancet (London, England), 2009, Aug-15, Volume: 374, Issue:9689 Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents	2009

Article

Year

Drug-induced fibrotic valvular heart disease.

Lancet (London, England), 2009, Aug-15, Volume: 374, Issue:9689

Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents

2009

Other Studies

8 other study(ies) available for ergotamine and Fibrosis

Article	Year
Multi-system fibrosis and long-term use of ergotamine. Annals of the Academy of Medicine, Singapore, 2011, Volume: 40, Issue:7 Topics: Adult; Echocardiography; Ergotamine; Female; Fibrosis; Humans; Migraine Disorders; Serotonin Receptor Agonists	2011
Fibrosis due to ergot derivatives: exposure to risk should be weighed up. Prescrire international, 2002, Volume: 11, Issue:62 Topics: Dihydroergotamine; Ergotamine; Fibrosis; France; Humans; Methysergide; Risk Assessment; Risk Factors	2002
[Pergolide treatment and cardiac valve pathology: the continuing saga of ergotamine-induced fibrosis]. Revue neurologique, 2004, Volume: 160, Issue:1 Topics: Dopamine Agonists; Ergotamine; Fibrosis; Heart Diseases; Heart Valve Diseases; Humans; Pergolide; Vasoconstrictor Agents	2004
Pleural and pericardial fibrosis after ergotamine therapy. Respiratory medicine, 1994, Volume: 88, Issue:6 Topics: Ergotamine; Fibrosis; Humans; Pericardium; Pulmonary Fibrosis	1994
Pleural and pericardial fibrosis after ergotamine therapy. Respiratory medicine, 1994, Volume: 88, Issue:1 Topics: Aged; Ergotamine; Female; Fibrosis; Humans; Pericardium; Pleura	1994
[Ergotamine-induced heart valve fibrosis]. Deutsche medizinische Wochenschrift (1946), 1993, Feb-12, Volume: 118, Issue:6 Topics: Ergotamine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans	1993
[Ergotamine-induced heart valve fibrosis and coronary microangiopathy?]. Deutsche medizinische Wochenschrift (1946), 1992, Nov-06, Volume: 117, Issue:45 Topics: Coronary Disease; Dihydroergotamine; Ergotamine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Mitral Valve Insufficiency	1992
Ergotamine, methysergide, and carcinoid-induced endocardial lesions. Archives of pathology & laboratory medicine, 1990, Volume: 114, Issue:6 Topics: Carcinoid Heart Disease; Endocardium; Ergotamine; Fibrosis; Humans; Methysergide	1990